• Inhibit NER and enhance the sensitivity of NER-proficient melanoma cells to cisplatin.• E-X PPI2 reduces ERCC1-XPF heterodimer levels in ovarian cancer cells.E-X PPI2 IC50 = 20 μM. Here, ERCC1 is linked to melanoma.